KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Dividends Paid - Common (2016 - 2025)

Historic Dividends Paid - Common for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to $1.3 billion.

  • Eli Lilly's Dividends Paid - Common rose 1492.52% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 billion, marking a year-over-year increase of 1493.53%. This contributed to the annual value of $4.7 billion for FY2024, which is 1501.73% up from last year.
  • Latest data reveals that Eli Lilly reported Dividends Paid - Common of $1.3 billion as of Q3 2025, which was up 1492.52% from $1.3 billion recorded in Q2 2025.
  • In the past 5 years, Eli Lilly's Dividends Paid - Common ranged from a high of $1.3 billion in Q2 2025 and a low of $768.3 million during Q2 2021
  • Its 5-year average for Dividends Paid - Common is $1.0 billion, with a median of $1.0 billion in 2023.
  • Over the last 5 years, Eli Lilly's Dividends Paid - Common had its largest YoY gain of 1541.79% in 2021, and its largest YoY loss of 1395.73% in 2021.
  • Over the past 5 years, Eli Lilly's Dividends Paid - Common (Quarter) stood at $773.3 million in 2021, then increased by 14.37% to $884.4 million in 2022, then rose by 15.12% to $1.0 billion in 2023, then grew by 14.75% to $1.2 billion in 2024, then rose by 15.14% to $1.3 billion in 2025.
  • Its Dividends Paid - Common was $1.3 billion in Q3 2025, compared to $1.3 billion in Q2 2025 and $1.3 billion in Q1 2025.